genOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models

Author's Avatar
Jan 07, 2020
Article's Main Image

genOway acquires additional rights to develop all animal cell models using the CRISPR/Cas9 system

PR Newswire